2021
May 25: Poised for revenue momentum
March 8: Progress in multiple regions
2020
November 24: Approvals in the UAE and Saudi Arabia
September 29: Q220 results
May 28: Multiple registrations underway
March 18: Expanding further into assisted care solutions
2019
November 4: Moving to commercial status
September 5: CE marks for Actiste device received
June 13: Waiting on the CE mark
March 5: Recent capital injection to fuel first sales
2018
September 25: Data-driven diabetes management as a service
2021
April 16: Genombrottsorder på flera marknader
2020
October 13: Imminent Regulatory Approvals
June 10: Telemedicine – an obvious choice for diabetes
March 6: Financing buys time
2019
October 29: In waiting mode
September 10: Risk reduced with CE news
June 25: Finansiering ger utrymme (SE)
2018
November 29: I väntans tider för Brighter (SE)
September 11: Temperaturen ökar långsamt (SE)
June 26: Potentialen kvarstår (SE)